158 related articles for article (PubMed ID: 11837283)
1. Open label extension studies and the ethical design of clinical trials.
Casarett D; Karlawish J; Sankar P; Hirschman KB; Asch DA
IRB; 2001; 23(4):1-5. PubMed ID: 11837283
[No Abstract] [Full Text] [Related]
2. A taxonomy of value in clinical research.
Casarett DJ; Karlawish JH; Moreno JD
IRB; 2002; 24(6):1-6. PubMed ID: 12683394
[No Abstract] [Full Text] [Related]
3. Recurrent issues in the review of medical research on human subjects.
Moore DL
Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
[No Abstract] [Full Text] [Related]
4. Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.
Daugherty CK; Banik DM; Janish L; Ratain MJ
IRB; 2000; 22(3):6-14. PubMed ID: 11697385
[No Abstract] [Full Text] [Related]
5. The problem with optimism in clinical trials.
Jansen LA
IRB; 2006; 28(4):13-9. PubMed ID: 17036434
[No Abstract] [Full Text] [Related]
6. Who should go first in trials with scarce agents? The views of potential participants.
Pentz RD; Flamm AL; Sugarman J; Cohen MZ; Xu Z; Herbst RS; Abbruzzese JL
IRB; 2007; 29(4):1-6. PubMed ID: 17847620
[No Abstract] [Full Text] [Related]
7. Difficulties in negotiating research access.
Ames JC; Thompson S; Thurston MN
Bull Med Ethics; 2001 Mar; (166):15-7. PubMed ID: 11878334
[No Abstract] [Full Text] [Related]
8. Caregivers as subjects of clinical drug trials: a review of human subjects protection practices in published studies of Alzheimer's disease pharmacotherapies.
Lingler JH; Parker LS; DeKosky ST; Schulz R
IRB; 2006; 28(3):11-8. PubMed ID: 17036439
[No Abstract] [Full Text] [Related]
9. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.
Horng S; Grady C
IRB; 2003; 25(1):11-6. PubMed ID: 12833900
[No Abstract] [Full Text] [Related]
10. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
Caulfield T
Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
[No Abstract] [Full Text] [Related]
11. Assessing benefits in clinical research: why diversity in benefit assessment can be risky.
Churchill LR; Nelson DK; Henderson GE; King NM; Davis AM; Leahey E; Wilfond BS
IRB; 2003; 25(3):1-8. PubMed ID: 14569987
[No Abstract] [Full Text] [Related]
12. Can underpowered clinical trials be justified?
Rosoff PM
IRB; 2004; 26(3):16-9. PubMed ID: 15281196
[No Abstract] [Full Text] [Related]
13. [Clinical study of antalgic drugs].
Dubray C
Therapie; 1999; 54(1):135-45. PubMed ID: 10216437
[TBL] [Abstract][Full Text] [Related]
14. [Attitudes toward and experiences with clinical research among current and potential research subjects].
Madsen SM
Ugeskr Laeger; 2004 Jun; 166(24):2343-4. PubMed ID: 15281573
[No Abstract] [Full Text] [Related]
15. Clinical trials registration in India: no longer a dream.
Tharyan P
Trop Gastroenterol; 2008; 29(1):1-3. PubMed ID: 18564658
[No Abstract] [Full Text] [Related]
16. Assuring the ethical conduct of clinical cancer trials in the developing world.
Markman M
Cancer; 2006 Jan; 106(1):1-3. PubMed ID: 16302227
[No Abstract] [Full Text] [Related]
17. "You may have already won..": an examination of the use of lottery payments in research.
Brown JS; Schonfeld TL; Gordon BG
IRB; 2006; 28(1):12-6. PubMed ID: 16680874
[No Abstract] [Full Text] [Related]
18. [Clinical study of analgesic drugs demonstrating a protocol for statistical analysis].
Rigolot JC; Vergnes
Anesth Analg (Paris); 1977; 34(1):39-46. PubMed ID: 327852
[No Abstract] [Full Text] [Related]
19. Ten questions institutional review boards should ask when reviewing international clinical research protocols.
Fitzgerald DW; Wasunna A; Pape JW
IRB; 2003; 25(2):14-8. PubMed ID: 12833903
[No Abstract] [Full Text] [Related]
20. Thinking further about value: commentary on "A taxonomy of value in clinical research".
Grady C
IRB; 2002; 24(6):7-8. PubMed ID: 12683395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
